I.G. Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$428M Buy
12,622,871
+2,157,191
+21% +$69.3M 2.19% 11
2017
Q2
$334M Sell
10,465,680
-1,078,673
-9% -$34M 1.72% 11
2017
Q1
$375M Sell
11,544,353
-142,277
-1% -$4.49M 1.92% 10
2016
Q4
$360M Buy
11,686,630
+2,313,254
+25% +$70.6M 1.89% 11
2016
Q3
$301M Buy
9,373,376
+147,510
+2% +$4.93M 1.17% 13
2016
Q2
$308M Sell
9,225,866
-1,417,170
-13% -$45.2M 1.22% 15
2016
Q1
$299M Buy
10,643,036
+1,989,205
+23% +$56.8M 1.21% 14
2015
Q4
$265M Sell
8,653,831
-620,359
-7% -$19.5M 1.13% 17
2015
Q3
$276M Buy
9,274,190
+148,215
+2% +$4.75M 1.16% 17
2015
Q2
$290M Sell
9,125,975
-1,376,399
-13% -$44.9M 1.1% 19
2015
Q1
$347M Sell
10,502,374
-1,571,428
-13% -$50M 1.32% 15
2014
Q4
$357M Buy
12,073,802
+142,582
+1% +$4.09M 1.29% 17
2014
Q3
$335M Buy
11,931,220
+2,736,190
+30% +$76.8M 1.2% 18
2014
Q2
$259M Buy
9,195,030
+851,963
+10% +$24.3M 0.89% 24
2014
Q1
$254M Buy
8,343,067
+833,670
+11% +$24.9M 0.91% 26
2013
Q4
$218M Sell
7,509,397
-4,907
-0.1% -$143K 0.79% 26
2013
Q3
$205M Buy
7,514,304
+360,771
+5% +$9.82M 0.78% 27
2013
Q2
$190M Buy
+7,153,533
New +$198M 0.77% 25

Other funds holding PFE

I.G. Investment Management's PFE Position: Q3 2017 in Review

I.G. Investment Management increased its Pfizer (PFE) stake by 21% in Q3 2017, buying an estimated $69.3M and bringing the position to 12,622,871 shares worth $428M. The position accounts for 2.19% of the portfolio, ranked #11.

I.G. Investment Management first reported a position in PFE in Q2 2013 and has held it in 18 quarters since. 2,041 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • I.G. Investment Management held 12,622,871 shares of Pfizer worth $428M as of Q3 2017.
  • I.G. Investment Management bought 2,157,191 Pfizer shares in Q3 2017, an estimated $69.3M.
  • Pfizer made up 2.19% of I.G. Investment Management's portfolio in Q3 2017, its #11 holding.
  • I.G. Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 18 quarters since.
  • 2,041 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on I.G. Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.